Verity Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.11M Buy
9,202
+476
+5% +$55K 0.46% 64
2025
Q4
$918K Buy
8,726
+187
+2% +$17.6K 0.39% 67
2025
Q3
$717K Buy
8,539
+159
+2% +$13.1K 0.23% 102
2025
Q2
$663K Sell
8,380
-19
-0.2% -$1.51K 0.32% 81
2025
Q1
$754K Sell
8,399
-375
-4% -$35K 0.31% 94
2024
Q4
$779K Buy
8,774
+526
+6% +$54.2K 0.44% 58
2024
Q3
$932K Buy
8,248
+611
+8% +$72.6K 0.35% 76
2024
Q2
$946K Buy
7,637
+2
+0% +$258 0.37% 66
2024
Q1
$1.01M Buy
7,635
+2
+0% +$247 0.56% 42
2023
Q4
$832K Sell
7,633
-35
-0.5% -$3.63K 0.53% 48
2023
Q3
$789K Sell
7,668
-215
-3% -$23.2K 0.58% 48
2023
Q2
$910K Buy
7,883
+25
+0.3% +$2.84K 0.67% 41
2023
Q1
$836K Buy
7,858
+361
+5% +$39K 0.5% 60
2022
Q4
$832K Sell
7,497
-2,139
-22% -$219K 0.71% 44
2022
Q3
$830K Buy
+9,636
New +$860K 0.86% 33
2022
Q1
$775K Buy
9,434
+1,666
+21% +$131K 0.49% 64
2021
Q4
$595K Buy
7,768
+179
+2% +$14.3K 0.35% 81
2021
Q3
$570K Sell
7,589
-708
-9% -$53.8K 0.37% 78
2021
Q2
$645K Buy
8,297
+505
+6% +$37.6K 0.35% 80
2021
Q1
$573K Buy
7,792
+915
+13% +$67.5K 0.34% 86
2020
Q4
$537K Buy
6,877
+1,038
+18% +$79.4K 0.37% 74
2020
Q3
$462K Buy
5,839
+441
+8% +$34.5K 0.35% 70
2020
Q2
$306K Buy
5,398
+961
+22% +$72.3K 0.28% 89
2020
Q1
$326K Buy
4,437
+1,911
+76% +$150K 0.41% 76
2019
Q4
$219K Buy
+2,526
New +$207K 0.22% 114

Other funds holding MRK

Verity Asset Management's MRK Position: Q1 2026 in Review

Verity Asset Management increased its Merck (MRK) stake by 5.5% in Q1 2026, buying an estimated $55K and bringing the position to 9,202 shares worth $1.11M. The position accounts for 0.46% of the portfolio, ranked #64.

Verity Asset Management first reported a position in MRK in Q4 2019 and has held it in 25 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Verity Asset Management held 9,202 shares of Merck worth $1.11M as of Q1 2026.
  • Verity Asset Management bought 476 Merck shares in Q1 2026, an estimated $55K.
  • Merck made up 0.46% of Verity Asset Management's portfolio in Q1 2026, its #64 holding.
  • Verity Asset Management first reported a position in Merck in Q4 2019 and has held it in 25 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Verity Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.